Given the strong evidence for SETD2-dependent regulation of alternative splicing, and the suggested existence of ATG12 isoforms issue of alternative splicing for, we speculated that dysregulation of SETD2 might impact on the differential expression of these ATG12 isoforms in RCC cells. Here, SETD2 is linked to renal cell carcinoma.